These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7437594)

  • 21. In vitro modelling of human tumour behaviour in drug discovery programmes.
    Baguley BC; Marshall ES
    Eur J Cancer; 2004 Apr; 40(6):794-801. PubMed ID: 15120035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model.
    Desaknai S; Lumniczky K; Esik O; Hamada H; Safrany G
    J Gene Med; 2003 May; 5(5):377-85. PubMed ID: 12731086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
    Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
    Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling the balance between quiescence and cell death in normal and tumour cell populations.
    Spinelli L; Torricelli A; Ubezio P; Basse B
    Math Biosci; 2006 Aug; 202(2):349-70. PubMed ID: 16697424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study of the need for the dearterialization of tumors].
    Chissov VI; Rusakov KG; Shchitkov KG; Igitov VI; Il'ina AI
    Eksp Onkol; 1984; 6(4):66-70. PubMed ID: 6499756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors specifically kill nonproliferating tumour cells.
    Burgess A; Ruefli A; Beamish H; Warrener R; Saunders N; Johnstone R; Gabrielli B
    Oncogene; 2004 Sep; 23(40):6693-701. PubMed ID: 15235588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative biophysical aspects of responses of tumours and normal tissues to ionizing radiations.
    Barendsen GW
    Curr Top Radiat Res Q; 1973 Oct; 9(1):101-8. PubMed ID: 4800957
    [No Abstract]   [Full Text] [Related]  

  • 31. Human tumour radiobiology: clinical data.
    Trott KR
    Strahlentherapie; 1983 Jul; 159(7):393-7. PubMed ID: 6612756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer.
    Rockwell S
    Br J Cancer Suppl; 1980 Apr; 4():118-22. PubMed ID: 6932914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proliferation kinetics of different types of tumors undergoing fractionated irradiation].
    Karakulov RK; Pelevina II
    Med Radiol (Mosk); 1981 Jul; 26(7):39-46. PubMed ID: 7289805
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spatio-temporal development of Walker tumor implanted in the stomach wall of the Wistar rat].
    Santini R; Brard E
    C R Seances Soc Biol Fil; 1976; 170(6):1239-42. PubMed ID: 140742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetics of the changes in the electrophoretic mobility of ascitic tumor cells differing in the sedimentation rate in the tumor growth process].
    Slivinskiĭ GG
    Tsitologiia; 1983 Feb; 25(2):221-7. PubMed ID: 6344369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Features and limitations of the in vivo evaluation of tumour response by optical means.
    Reinhold HS; Berg-Blok A
    Br J Cancer Suppl; 1980 Apr; 4():64-8. PubMed ID: 6932947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of x-irradiation on cell loss in five solid murine tumours, as determined by the 125IUdR method.
    Kelley SD; Kallman RF; Rapacchietta D; Franko AJ
    Cell Tissue Kinet; 1981 Nov; 14(6):611-24. PubMed ID: 7296627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The tumour-tetanus phenomenon as a basis for computation of cell kinetic parameters of tumour growth (author's transl)].
    Schmidt W; Schneeweiss U; Fabricius EM
    Arch Geschwulstforsch; 1982; 52(1):29-40. PubMed ID: 7044338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities.
    Siemann DW
    Br J Cancer Suppl; 1980 Apr; 4():294-8. PubMed ID: 6932939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial-cell proliferation in experimental tumours.
    Denekamp J; Hobson B
    Br J Cancer; 1982 Nov; 46(5):711-20. PubMed ID: 7171453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.